This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!

Michael Alonso, Ph.D.
Vice President, Immunology and Pharmacology at Bolt Biotherapeutics


Michael Alonso, Ph.D., Vice President, Immunology & Pharmacology, is a scientific co-founder at Bolt Biotherapeutics and co-invented Bolt’s promising technology. Michael is passionate about translating scientific discoveries into therapies that ensure cancer patients become cancer survivors. Dr. Alonso has deep expertise with myeloid biology earned his Ph.D. from Stanford University School of Medicine and his Certificate in Entrepreneurship from Stanford’s Graduate School of Business.

Agenda Sessions

  • BoltbodyTM Immune-Stimulating Antibody Conjugates (ISACs): A New Class of Tumor-Targeted Immunotherapeutics

    On Demand
  • Payloaded Antibodies and Immune-oncology – Crossroads